Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by molecular dynamics simulations M Parmar, R Thumar, B Patel, M Athar, PC Jha, D Patel Structural Chemistry 34 (4), 1309-1326, 2023 | 22 | 2023 |
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1. 1.529 (Omicron) variant using computational approaches M Parmar, R Thumar, J Sheth, D Patel Structural Chemistry 33 (6), 2243-2260, 2022 | 11 | 2022 |
Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach N Rana, D Patel, M Parmar, N Mukherjee, PC Jha, A Manhas Scientific Reports 13 (1), 18090, 2023 | 10 | 2023 |
Biochemistry, mechanistic intricacies, and therapeutic potential of Antimicrobial Peptides: an alternative to traditional Antibiotics M Dwivedi, MD Parmar, D Mukherjee, A Yadava, H Yadav, NP Saini Current Medicinal Chemistry 31 (37), 6110-6139, 2024 | 4 | 2024 |
Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights for Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations M Parmar, R Thumar, B Patel, M Athar, PC Jha, D Patel bioRxiv, 2021.08. 11.455903, 2021 | 2 | 2021 |